ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,216.25
-1.06%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Dr Reddys Laboratories Ltd (RDY)

  7. Dr Reddys Laboratories Ltd (RDY) Noticias

RDY Dr Reddys Laboratories Ltd

75.21
0.43 (0.58%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dr Reddys Laboratories Ltd RDY NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.43 0.58% 75.21 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
74.89 74.705 75.43 75.21 74.78
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/5/202407:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
22/3/202406:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
19/3/202406:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
04/3/202405:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202405:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202405:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202405:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202405:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202405:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202407:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202405:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202405:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202411:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/2/202409:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202405:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202408:44BWDr. Reddy’s Q3 & 9M FY24 Financial Results
31/1/202406:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202413:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202412:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202410:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202405:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202409:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202410:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202407:58DJNIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky..
16/1/202405:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202407:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202405:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202405:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202405:00BWDr. Reddy's Announces the Acquisition of MenoLabs®, a..
02/1/202405:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202405:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202307:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202306:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202305:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/12/202305:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202306:49BWDr. Reddy’s becomes first Indian pharma company to debut on..
12/12/202305:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202305:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202311:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202310:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202306:55DJNCoya Therapeutics Strikes Development, Commercialization..
06/12/202306:00BWCoya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter..
01/12/202306:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202307:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202306:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202308:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202307:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202305:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NYSE
RDY
Dr Reddys Laboratories
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados